title: [Are there gender-related differences in the therapeutic management of patients suffering from inflammatory bowel disease? Subgroup analysis of a prospective multicentre online-based trial].
abstract: BACKGROUND
  The most frequently prescribed medications for patients suffering from inflammatory bowel disease (IBD) in the Rhein-Main region of Germany are aminosalicylates and corticosteroids irrespective of the disease activity. In contrast, immunomodulators only play a marginal role. As anti-TNF therapy is very costly, it is prescribed in outpatient services of hospitals rather than in gastroenterological practices.
  
  
  OBJECTIVE
  The aim of this study was to evaluate possible gender-related differences in the therapeutic management of IBD patients treated in the Rhein-Main region of Germany.
  
  
  METHODS
  Data records about past medical history, disease status, laboratory values and medical treatment of outpatients of 10 gastroenterological practices and 3 hospitals were collected from November 1st 2005 to July 31st 2007 and analysed with regard to gender-related differences in therapy and disease management.
  
  
  RESULTS
  Overall, no statistically significant difference in gender-specific medical treatment could be observed in the study cohort. However, detailed analyses revealed, that 1. women suffering from IBD, who are treated in outpatient services of hospitals, are more often under immunosuppressants, irrespective of disease activity, 2. in gastroenterological practices less than 3 % of patients are prescribed any immunosuppressive therapy (vs. 17 % [men] und 42 % [women] in hospital outpatient services), and 3. anti-TNF therapy is applied more frequently in men as compared to women in hospital outpatient services in both remission and active disease.
  
  
  CONCLUSIONS
  This study discloses the gender-specific differences in the therapeutic management of IBD patients in a congested urban area in Germany. Further studies are required to confirm the tendencies detected.
authors.affiliation: Zentrum der Inneren Medizin, Medizinische Klinik 1, Schwerpunkt Gastroenterologie Hepatologie, Johann Wolfgang Goethe-Universität Frankfurt am Main. Irina.Blumenstein@kgu.de
authors.forename: I
authors.initials: I
authors.lastname: Blumenstein
authors.forename: H
authors.initials: H
authors.lastname: Bock
authors.forename: C
authors.initials: C
authors.lastname: Zosel
authors.forename: A U
authors.initials: AU
authors.lastname: Dignass
authors.forename: F
authors.initials: F
authors.lastname: Hartmann
authors.forename: S
authors.initials: S
authors.lastname: Zeuzem
authors.forename: J M
authors.initials: JM
authors.lastname: Stein
authors.forename: O
authors.initials: O
authors.lastname: Schroeder
mesh_terms: D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy*; D020407:Internet; D008297:Male; D015995:Prevalence; D011446:Prospective Studies; D017678:Sex Distribution; D016896:Treatment Outcome